Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer.

Name: Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer.
Author: Kitagawa, Chiyoe

Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer. — المؤلف: Kitagawa, Chiyoe — In vivo (Athens, Greece) 20190404

المؤلف: Kitagawa, Chiyoe
النشر: In vivo (Athens, Greece) 20190404
الوصف: 163-166 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Anthracyclines؛ Carcinoma, Non-Small-Cell Lung؛ Dose-Response Relationship, Drug؛ Female؛ Humans